Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: Creo Medical board members add to holdings
(Sharecast News) - Creo Medical Group had several entries on the list of director buys on Friday, after it disclosed three share purchases made by two of its board members. The AIM-traded firm said non-executive chairman Charles Spicer purchased 15,435 shares at a price of 97.18p each, spending a total of £14,999.73.
Following the transaction, Spicer's total direct interest in the company held via his self-invested personal pension was now 143,411 shares, representing 0.08% of its issued capital.
Chief financial officer Richard Rees, meanwhile, purchased a total of 70,000 shares at a price of 96.75p apiece.
It said Rees purchased 21,400 of those into his self-invested pension plan, for a total of £20,704.50, while the remaining 48,600 were purchased for a total value of £47,020.50.
Creo said Rees' total direct interest in the company was now 73,615 shares, representing 0.04% of its issued capital.
Reporting by Josh White at Sharecast.com.
Top Director Buys
I3 Energy (I3E) Director name: Festival,John Amount purchased: 354,500 @ $0.44 Value: $91,230.90
Surface Transforms (SCE) Director name: Cleminson,Ian Amount purchased: 102,053 @ 49.00p Value: £50,005.97
Bakkavor Group (BAKK) Director name: Lodge ,Jane Ann Amount purchased: 50,000 @ 100.00p Value: £50,000.00
Smithson Investment Trust (SSON) Director name: Bartlett,Diana Dyer Amount purchased: 3,886 @ 1,280.00p Value: £49,740.80
Creo Medical Group (CREO) Director name: Rees,Richard John Amount purchased: 48,600 @ 96.75p Value: £47,020.50
Creo Medical Group (CREO) Director name: Rees,Richard John Amount purchased: 21,400 @ 96.75p Value: £20,704.50
Creo Medical Group (CREO) Director name: Spicer,Charles Amount purchased: 15,435 @ 97.18p Value: £14,999.73
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
